Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319
基于成纤维细胞生长因子 21 的临床候选药物 LY2405319 的合理设计
期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0058575
Alexei Kharitonenkov, John M Beals, Radmila Micanovic, Beth A Strifler, Radhakrishnan Rathnachalam, Victor J Wroblewski, Shun Li, Anja Koester, Amy M Ford, Tamer Coskun, James D Dunbar, Christine C Cheng, Christopher C Frye, Thomas F Bumol, David E Moller
